ASCME Study

ASCME Study Project led by Dr. Paxton Bach, MD, at the University of British Columbia

The ASCME trial is testing whether high-dose lisdexamfetamine (Vyvanse) and contingency management alongside usual treatment can help reduce or stop methamphetamine use.

Hello Everyone,Our clinical research team is recruiting participants for a study exploring new treatment options for ind...
01/19/2026

Hello Everyone,
Our clinical research team is recruiting participants for a study exploring new treatment options for individuals who use methamphetamine. Participation is entirely voluntary, and compensation is provided.
The study is evaluating whether Vyvanse (a stimulant medication) and/or Contingency Management (a behavioural intervention), in combination with usual substance use treatment, can support individuals who are interested in reducing or stopping their methamphetamine use.
The ASCME Study is led by addiction medicine specialist Dr. Paxton Bach, MD, and is a collaboration between the BC Centre on Substance Use, Providence Health Care, and the University of British Columbia.
If you’d like more information, please visit our websites or contact our Research Coordinator at 236-688-7273 if you’re interested in participating.
https://www.bccsu.ca/ascme/
https://www.providenceresearch.ca/.../ascme-clinical-trial
https://app.reachbc.ca/project/study/902
Please note: Your interaction with this post may be visible to others depending on your personal privacy settings. Consider reviewing your settings to manage who can see your activity.
Warmly,
The ASCME Study Team

08/06/2025
Hello Everyone,I'm reaching out to share information about a clinical trial currently underway at the Rapid Access Addic...
08/06/2025

Hello Everyone,

I'm reaching out to share information about a clinical trial currently underway at the Rapid Access Addiction Clinic (RAAC) at St. Paul’s Hospital.

Our clinical research team is recruiting participants for a study exploring new treatment options for individuals who use methamphetamine. Participation is entirely voluntary, and compensation is provided.

The study is evaluating whether Vyvanse (a stimulant medication) and/or Contingency Management (a behavioural intervention), in combination with usual substance use treatment, can support individuals who are interested in reducing or stopping their methamphetamine use.

The ASCME Study is led by addiction medicine specialist Dr. Paxton Bach, MD, and is a collaboration between the BC Centre on Substance Use, Providence Health Care, and the University of British Columbia.

If you’d like more information, please visit our websites or contact our Research Coordinator at 236-688-7273 if you’re interested in participating.

https://www.bccsu.ca/ascme/

https://www.providenceresearch.ca/en/clinical-trials/ascme-clinical-trial

https://www.reachbc.ca/project/902?fbclid=IwY2xjawMAgbpleHRuA2FlbQIxMABicmlkETFhdG9JN3FYbkpBZ0tJeDNsAR4Z2Pys7EwKEYh6NP_ltSUpq-tfX9ppM7oBSZNd_jx8TgL_5u-ztEBA45F7zQ_aem_D_nhMM8n86J5094M16UFNQ

Please note: Your interaction with this post may be visible to others depending on your personal privacy settings. Consider reviewing your settings to manage who can see your activity.

Warmly,
The ASCME Study Team

Address

1081 Burrard Street
Vancouver, BC
V6Z1Y6

Opening Hours

Monday 9am - 4pm
Tuesday 9am - 4pm
Wednesday 9am - 4pm
Thursday 9am - 4pm
Friday 9am - 4pm

Alerts

Be the first to know and let us send you an email when ASCME Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share